
TearSolutions
Developer of a peptide therapy designed for the treatment of signs and symptoms of dry eye in primary sjögren's syndrome patients. The company's product helps patient preserves all of the biological a...
Valuation
$0
Share Price
N/A
Total Raised
$44.1M
Last Round
N/A